Reducing Doxorubicin Cardiotoxicity With Dapsone, Febuxostat, Telmisartan.

Saki N, Kast RE, Bahreiny SS, Aghaei M

DOI: 10.32598/ari.81.1.3165
Published: 2026 Jan
Container: Archives of Razi Institute
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.32598/ari.81.1.3165,
  title = {Reducing Doxorubicin Cardiotoxicity With Dapsone, Febuxostat, Telmisartan.},
  author = {Saki N and Kast RE and Bahreiny SS and Aghaei M},
  year = {2026},
  journal = {Archives of Razi Institute},
  doi = {10.32598/ari.81.1.3165},
  url = {https://doi.org/10.32598/ari.81.1.3165}
}

RIS

TY  - JOUR
TI  - Reducing Doxorubicin Cardiotoxicity With Dapsone, Febuxostat, Telmisartan.
AU  - Saki N
AU  - Kast RE
AU  - Bahreiny SS
AU  - Aghaei M
PY  - 2026
JO  - Archives of Razi Institute
DO  - 10.32598/ari.81.1.3165
UR  - https://doi.org/10.32598/ari.81.1.3165
ER  -

APA

N, S., RE, K., SS, B., & M, A. (2026). Reducing Doxorubicin Cardiotoxicity With Dapsone, Febuxostat, Telmisartan.. Archives of Razi Institute. https://doi.org/10.32598/ari.81.1.3165

Source records

pubmed · retrieved 2026-11-08T14:03:45.669Z